Patent · US Active

Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor

US8962644B2 · kind B2 · utility

1Cited by

23References

4Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

James P. Edwards · San Diego, US
David E. Kindrachuk · Encinitas, US
Christopher M. Mapes · Village of La Jolla, US
Daniel J. Pippel · Del Mar, US
Jennifer D. Venable · Solana Beach, US

Key dates

Filing date	Oct 11, 2013
Grant date	Feb 24, 2015
Priority date	—
Expiry date	Oct 11, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/4184
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Benzoimidazol-2-yl pyrimidines and pyrazines, pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.